News Merck/Pfizer undercut rivals with newly approved diabetes dr... Steglatro cheaper than SGLT2 rivals from AZ and Lilly/Boehringer
News Pfizer's Xeljanz approved in psoriatic arthritis Xeljanz is first JAK inhibitor approved in psoriatic arthritis
News Pfizer's Ibrance available across UK after thumbs up in Scot... Around 800 women have received the drug for free.
News Novartis aims to broaden use of breast cancer drug Study shows Kisqali extends survival in younger women with aggressive disease
News Dance Biopharm to develop inhaled insulin with Phillips-Medi... Biotech working on soft mist insulin delivery device with IT firm
News Eisai: UK gives pharma a poor deal, may invest elsewhere Japanese pharma getting frustrated with NICE
Patients Making direct-to-patient work, with Matt Wadyka Matt Wadyka, chief client strategy officer at Inizio Medical, spoke to pharmaphorum about the ins and outs of direct-to-patient programmes in pharma.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
